• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

11 个肥胖候选基因标志物与 SOS 减重手术病例最大减重和体重反弹的相关性。

Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases.

机构信息

Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA.

出版信息

Int J Obes (Lond). 2011 May;35(5):676-83. doi: 10.1038/ijo.2010.166. Epub 2010 Aug 24.

DOI:10.1038/ijo.2010.166
PMID:20733583
Abstract

PURPOSE

To test whether DNA sequence variation in 11 obesity genes is associated with maximum weight loss and weight regain over 6 years of follow-up in bariatric surgery patients of the Swedish obese subjects (SOS) intervention study.

METHODS

A total of 1443 subjects were available for analysis (vertical banded gastroplasty: n = 966, banding: n = 293 and gastric bypass: n = 184). Single-nucleotide polymorphisms (SNPs) from the following 11 genes were included: ADIPOQ, BDNF, FTO, GNB3, LEP, LEPR, MC4R, NR3C1, PPARG, PPARGC1A and TNF. General linear models were used to analyze associations between the SNPs and maximum weight loss and weight regain.

RESULTS

The average maximum weight loss was 33.7 kg (s.d. 13.3; min -95.5 kg, max +2.0 kg), which was reached 2.2 (s.d. 1.6) years after the surgery. Subjects regained approximately 12 kg (range 0.0-51.4 kg) by year 6. After correcting for multiple testing, the FTO SNP rs16945088 remained significantly associated with maximum weight loss (P = 0.0002), as minor allele carriers lost approximately 3 kg less compared with common allele homozygotes. This association was particularly evident in the banding surgery patients (P < 0.0001), whereas no significant association was found in the gastric bypass subjects. No other SNPs were associated with maximum weight loss. Furthermore, no SNPs were significantly associated with weight regain.

CONCLUSION

The FTO SNP rs16945088 was associated with maximum weight loss after banding surgery. We found no evidence that obesity-risk SNPs in FTO or other obesity candidate genes derived from genome-wide association studies are associated with maximum weight loss or weight regain over 6 years of follow-up in bariatric surgery patients. The potential role of other obesity genes remains to be investigated.

摘要

目的

检测肥胖基因 11 个基因中的 DNA 序列变异是否与减肥手术患者随访 6 年期间的最大减重和体重反弹有关。

方法

共对 1443 例患者进行分析(垂直束带胃成形术:n=966 例,束带术:n=293 例,胃旁路术:n=184 例)。纳入以下 11 个基因的单核苷酸多态性(SNP):ADIPOQ、BDNF、FTO、GNB3、LEP、LEPR、MC4R、NR3C1、PPARG、PPARGC1A 和 TNF。采用线性回归模型分析 SNP 与最大减重和体重反弹的关系。

结果

平均最大减重为 33.7kg(标准差 13.3kg;最小值-95.5kg,最大值+2.0kg),术后 2.2 年(标准差 1.6 年)达到减重高峰。随访 6 年后,患者体重反弹约 12kg(0.0-51.4kg)。经过多重检验校正后,FTO 基因 SNP rs16945088 与最大减重仍显著相关(P=0.0002),携带该 SNP 少数等位基因的患者比常见等位基因纯合子患者的减重少约 3kg。这种相关性在束带手术患者中尤为明显(P<0.0001),而在胃旁路手术患者中则无显著相关性。其他 SNP 与最大减重均无显著相关性。此外,没有 SNP 与体重反弹显著相关。

结论

FTO 基因 SNP rs16945088 与束带手术后的最大减重相关。我们没有发现来自全基因组关联研究的 FTO 或其他肥胖候选基因中的肥胖风险 SNP 与减肥手术后 6 年的最大减重或体重反弹相关。其他肥胖基因的潜在作用仍有待研究。

相似文献

1
Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases.11 个肥胖候选基因标志物与 SOS 减重手术病例最大减重和体重反弹的相关性。
Int J Obes (Lond). 2011 May;35(5):676-83. doi: 10.1038/ijo.2010.166. Epub 2010 Aug 24.
2
Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery.胃束带手术前后病态肥胖受试者中瘦素、白细胞介素6和脂联素基因单核苷酸多态性与其循环产物之间的关系。
Obes Surg. 2005 Jan;15(1):11-23. doi: 10.1381/0960892052993431.
3
Body composition changes after laparoscopic adjustable gastric banding: what is the role of -174G>C interleukin-6 promoter gene polymorphism in the therapeutic strategy?腹腔镜可调节胃束带术后体成分的变化:-174G>C 白细胞介素 6 启动子基因多态性在治疗策略中的作用是什么?
Int J Obes (Lond). 2012 Mar;36(3):369-78. doi: 10.1038/ijo.2011.132. Epub 2011 Jul 5.
4
Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter?超级肥胖与病态肥胖患者接受减肥手术后的结果:体重有影响吗?
Obes Surg. 1997 Oct;7(5):414-9. doi: 10.1381/096089297765555395.
5
A single FTO gene variant rs9939609 is associated with body weight evolution in a multiethnic extremely obese population that underwent bariatric surgery.单个FTO基因变体rs9939609与接受减肥手术的多民族极度肥胖人群的体重变化有关。
Nutrition. 2015 Nov-Dec;31(11-12):1344-50. doi: 10.1016/j.nut.2015.05.020. Epub 2015 Jun 25.
6
Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.瑞典肥胖受试者(SOS)试验的关键结果回顾-减肥手术的前瞻性对照干预研究。
J Intern Med. 2013 Mar;273(3):219-34. doi: 10.1111/joim.12012. Epub 2013 Feb 8.
7
Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.在一家大型减肥手术中心接受减肥手术的超级肥胖(BMI≥60 kg/m²)患者的短期结局:腹腔镜可调节胃束带术、腹腔镜胃旁路术和开放式管状胃旁路术。
Surg Obes Relat Dis. 2008 May-Jun;4(3):408-15. doi: 10.1016/j.soard.2007.10.013. Epub 2008 Feb 1.
8
[Obesity surgery in patients suffering from monogenetic adipositas].[患有单基因肥胖症患者的肥胖症手术]
Zentralbl Chir. 2007 Jun;132(3):256-9. doi: 10.1055/s-2007-981161.
9
Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study.重度肥胖手术治疗与传统治疗后健康相关生活质量的十年趋势:SOS干预研究
Int J Obes (Lond). 2007 Aug;31(8):1248-61. doi: 10.1038/sj.ijo.0803573. Epub 2007 Mar 13.
10
The intragastric balloon - smoothing the path to bariatric surgery.胃内球囊——为减肥手术铺平道路。
Obes Surg. 2006 Jul;16(7):897-902. doi: 10.1381/096089206777822188.

引用本文的文献

1
Polygenic Score for Body Mass Index Is Associated with Weight Loss and Lipid Outcomes After Metabolic and Bariatric Surgery.体重指数的多基因评分与代谢和减重手术后的体重减轻及脂质指标相关。
Int J Mol Sci. 2025 Jul 29;26(15):7337. doi: 10.3390/ijms26157337.
2
Rewriting cellular fate: epigenetic interventions in obesity and cellular programming.改写细胞命运:肥胖症和细胞编程中的表观遗传干预。
Mol Med. 2024 Oct 10;30(1):169. doi: 10.1186/s10020-024-00944-2.
3
Precision Medicine in Bariatric Procedures.减重手术中的精准医学。
Gastrointest Endosc Clin N Am. 2024 Oct;34(4):765-779. doi: 10.1016/j.giec.2024.03.004. Epub 2024 Apr 16.
4
The Outcome of Metabolic and Bariatric Surgery in Morbidly Obese Patients with Different Genetic Variants Associated with Obesity: A Systematic Review.肥胖相关基因变异对病态肥胖患者代谢和减重手术结局的影响:系统综述。
Nutrients. 2024 Aug 1;16(15):2510. doi: 10.3390/nu16152510.
5
Characterising the genetic architecture of changes in adiposity during adulthood using electronic health records.利用电子健康记录描述成年期体脂变化的遗传结构。
Nat Commun. 2024 Jul 10;15(1):5801. doi: 10.1038/s41467-024-49998-0.
6
Interaction Effects of and Polymorphisms on Total Body Weight Loss, Post-Surgery Weight, and Post-Body Mass Index after Bariatric Surgery.肥胖症手术后,[具体基因]多态性与[另一基因]多态性对总体重减轻、术后体重及术后体重指数的交互作用。
Genes (Basel). 2024 Mar 22;15(4):391. doi: 10.3390/genes15040391.
7
High Prevalence of Positive Genetic Obesity Variants in Postoperative Bariatric Surgery Patients with Weight Regain Presenting for Medical Obesity Intervention.接受医学肥胖干预的减肥手术后体重反弹患者中,遗传肥胖变异呈阳性的比例很高。
Obes Surg. 2024 Jan;34(1):170-175. doi: 10.1007/s11695-023-06952-1. Epub 2023 Nov 23.
8
A Clinical-Genetic Score for Predicting Weight Loss after Bariatric Surgery: The OBEGEN Study.一种预测减肥手术后体重减轻的临床-遗传评分:OBEGEN研究。
J Pers Med. 2021 Oct 17;11(10):1040. doi: 10.3390/jpm11101040.
9
Omics Approaches in Adipose Tissue and Skeletal Muscle Addressing the Role of Extracellular Matrix in Obesity and Metabolic Dysfunction.脂肪组织和骨骼肌中的组学方法解决细胞外基质在肥胖和代谢功能障碍中的作用
Int J Mol Sci. 2021 Mar 9;22(5):2756. doi: 10.3390/ijms22052756.
10
Strategies to Understand the Weight-Reduced State: Genetics and Brain Imaging.理解体重减轻状态的策略:遗传学和脑成像。
Obesity (Silver Spring). 2021 Apr;29 Suppl 1(Suppl 1):S39-S50. doi: 10.1002/oby.23101.